Close

Ritter Pharma (RTTR) Approves 1-for-10 Reverse Stock Split

March 1, 2018 4:35 PM EST Send to a Friend
Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutic products that modulate the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login